145 related articles for article (PubMed ID: 6354238)
21. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
[TBL] [Abstract][Full Text] [Related]
22. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
23. Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas.
Zhang L; Xiao Y; Priddy R
J Oral Pathol Med; 1994 Feb; 23(2):75-9. PubMed ID: 8164157
[TBL] [Abstract][Full Text] [Related]
24. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions.
Bryne M; Reibel J; Mandel U; Dabelsteen E
J Oral Pathol Med; 1991 Mar; 20(3):120-5. PubMed ID: 1709970
[TBL] [Abstract][Full Text] [Related]
25. Expression of blood group H antigen type 2 chain by oral carcinoma cells after radiotherapy.
Shabana AH; Ivanyi L; Kramer IR
Oral Surg Oral Med Oral Pathol; 1987 Mar; 63(3):340-7. PubMed ID: 3473361
[TBL] [Abstract][Full Text] [Related]
26. Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region?
Bryne M; Gravdahl C; Koppang HS; Kjaerheim A; Dabelsteen E
J Pathol; 1995 Feb; 175(2):237-42. PubMed ID: 7738720
[TBL] [Abstract][Full Text] [Related]
27. Changes in the expression of alpha v integrins in oral squamous cell carcinomas.
Jones J; Watt FM; Speight PM
J Oral Pathol Med; 1997 Feb; 26(2):63-8. PubMed ID: 9049904
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of Leu-M1 carbohydrate antigen in human oral squamous cell carcinoma.
Teng YT; Nadimi H; Toto PD
J Oral Pathol Med; 1989 Oct; 18(9):502-5. PubMed ID: 2691649
[TBL] [Abstract][Full Text] [Related]
29. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
30. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of the Ca antigen in normal and tumor tissues of humans by use of Ca1 monoclonal antibody.
Woodhouse CS; Seiler C; Morgan AC; Oldham RK
J Natl Cancer Inst; 1985 Feb; 74(2):383-9. PubMed ID: 3883035
[TBL] [Abstract][Full Text] [Related]
32. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions.
Stenersen TC; Dabelsteen E
APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523
[TBL] [Abstract][Full Text] [Related]
33. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
Fantozzi RD
Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies against squamous cell carcinoma.
Eskinazi DP; Molinaro GA; Abemayor E; Martin SE; Zighelboim J
Oral Surg Oral Med Oral Pathol; 1985 Oct; 60(4):377-81. PubMed ID: 3903597
[TBL] [Abstract][Full Text] [Related]
36. Detection of the tumor-associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon.
Wolf BC; D'Emilia JC; Salem RR; DeCoste D; Sears HF; Gottlieb LS; Steele GD
J Natl Cancer Inst; 1989 Dec; 81(24):1913-7. PubMed ID: 2593169
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical analysis of AE1/AE3, CK 14, Ki-67 and p53 expression in benign, premalignant and malignant oral tissue to establish putative markers for progression of oral carcinoma.
Farrar M; Sandison A; Peston D; Gailani M
Br J Biomed Sci; 2004; 61(3):117-24. PubMed ID: 15462255
[TBL] [Abstract][Full Text] [Related]
39. The immunohistology of CD40 in human oral epithelium in health and disease.
Villarroel Dorrego M; Speight PM; Barrett AW
J Oral Pathol Med; 2006 May; 35(5):268-73. PubMed ID: 16630289
[TBL] [Abstract][Full Text] [Related]
40. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
